Kuros' share price rally is not over yet

The small medtech company is celebrating great success on the market for bone replacement products and on the stock exchange. Simon Götschmann, fund manager of Arkudos 130/30 Swiss Equity Alpha and Kuros Investor, shares his views on the stock with Finanz+Wirtschaft.

Kuros 13.06.2024.pdf

Download PDF • 801KB